These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9337985

  • 1. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA, Roberts A, Montgomery SA, Cowen PJ.
    Br J Psychiatry; 1997 Sep; 171():280-2. PubMed ID: 9337985
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK.
    Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964
    [Abstract] [Full Text] [Related]

  • 3. Increased prolactin responses to d-fenfluramine in obsessive-compulsive disorder.
    Ramasubbu R.
    Br J Psychiatry; 1998 Feb 01; 172():186-7. PubMed ID: 9519076
    [No Abstract] [Full Text] [Related]

  • 4. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P, Catapano F, Bortolotti F, Maj M.
    Biol Psychiatry; 1997 Aug 01; 42(3):175-80. PubMed ID: 9232209
    [Abstract] [Full Text] [Related]

  • 5. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB, Williamson DJ, Cowen PJ.
    Psychol Med; 1996 Nov 01; 26(6):1191-6. PubMed ID: 8931165
    [Abstract] [Full Text] [Related]

  • 6. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct 01; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 7. Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.
    Monteleone P, Catapano F, Di Martino S, Ferraro C, Maj M.
    Br J Psychiatry; 1997 Jun 01; 170():554-7. PubMed ID: 9330023
    [Abstract] [Full Text] [Related]

  • 8. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Martin K, Berman S, Csernansky JG.
    Psychiatry Res; 1992 Apr 01; 42(1):81-92. PubMed ID: 1603884
    [Abstract] [Full Text] [Related]

  • 9. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May 01; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 10. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P, Brambilla F, Bortolotti F, Ferraro C, Maj M.
    Psychol Med; 1998 Jul 01; 28(4):975-83. PubMed ID: 9723152
    [Abstract] [Full Text] [Related]

  • 11. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun 01; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 13. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF.
    Biol Psychiatry; 1993 Sep 15; 34(6):407-13. PubMed ID: 8218609
    [Abstract] [Full Text] [Related]

  • 14. Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs.
    Delva NJ, Matthews DR, Cowen PJ.
    Biol Psychiatry; 1996 Jan 15; 39(2):100-6. PubMed ID: 8717607
    [Abstract] [Full Text] [Related]

  • 15. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 15; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 16. Improved serotonergic neurotransmission by genistein pretreatment regulates symptoms of obsessive-compulsive disorder in streptozotocin-induced diabetic mice.
    Phadnis P, Dey Sarkar P, Rajput MS.
    J Basic Clin Physiol Pharmacol; 2018 Jul 26; 29(4):421-425. PubMed ID: 29561730
    [Abstract] [Full Text] [Related]

  • 17. D-fenfluramine challenge in posttraumatic stress disorder.
    Davis LL, Clark DM, Kramer GL, Moeller FG, Petty F.
    Biol Psychiatry; 1999 Apr 01; 45(7):928-30. PubMed ID: 10202582
    [Abstract] [Full Text] [Related]

  • 18. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men.
    Walsh AE, Oldman AD, Franklin M, Fairburn CG, Cowen PJ.
    J Affect Disord; 1995 Feb 21; 33(2):89-97. PubMed ID: 7759666
    [Abstract] [Full Text] [Related]

  • 19. Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.
    Power AC, Dorkins CE, Cowen PJ.
    Biol Psychiatry; 1995 Feb 21; 33(11-12):801-5. PubMed ID: 8373918
    [Abstract] [Full Text] [Related]

  • 20. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P, Catapano F, Tortorella A, Maj M.
    Neuropsychobiology; 1997 Feb 21; 36(1):8-12. PubMed ID: 9211437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.